Final Activity: The appeals period closed on June 11, 2010.
An ad hoc review may be conducted on an endorsed standard at any time with adequate justification. The requestor is required to provide evidence supporting that the measure focus has changed; that implementation of the measure may result in unintended consequences; or that there has been a material change to the measure.
NQF conducted an ad hoc review for the endorsed measure, Discharged on Statin Medication (Endorsed measure: #0439).
About this Review
Reason for Request
NQF received a request to review Measure #0439, Discharged on Statin Medication. Currently, this measure applies to patients who were hospitalized due to stroke. The requestor has asked that this measure be expanded based on the evidence to address patients who are hospitalized due to an acute myocardial infarction (AMI).
Requestor's Submission: Details provided by requestor of the adhoc review (PDF)
Justification for Ad Hoc Review
Criterion 1: The evidence supporting the measure focus has changed and the measure does not reflect updated evidence.
Criterion 3: Material changes have been made to a currently endorsed measure (e.g. expansion of a measure to a different population or setting).
Requestor of Ad Hoc Review
Center for Medicare & Medicaid Services (CMS)
Associated NQF Project
National Voluntary Consensus Standards for Stroke Across the Continuum of Care
Project Overiew | View Abridged Report (PDF)
Process
Requests for ad hoc reviews will be considered by NQF on a case-by-case basis and must be justified by specific criteria.
Learn more about the NQF ad hoc review process.
Contact Information
For more information, please contact Heidi Bossley, MSN, MBA at 202-783-1300 or via e-mail at performancemeasures@qualityforum.org.
Upon receiving adequate justification, NQF has been conducting ad hoc reviews on endorsed standards. The measure, Discharged on Statin Medication (Endorsed measure: #0439), has been reviewed by a technical review panel.
Technical experts reviewed the evidence and any additional information provided by the ad hoc review requestor and measure steward. The technical experts will provide input to the Consensus Standards Approval Committee (CSAC) after the public and member comment periods.
The CSAC approved the recommendations of the technical review. To make their decision, the CSAC considered all information brought forth through the ad hoc review (including the assessment of the technical experts, public and Member comments, and input from the measure steward and requestor).
The NQF Board of Directors ratified the CSAC’s decision to continue endorsement of measure #0439 “Discharged on Statin Medication”.
The public had 30 days to appeal the final decision to endorse a voluntary consensus standard. The appeals process closed on June 11, 2010. No appeals were filed.
